TissueScan, Lung Cancer cDNA Array I

SKU
HLRT101
48 samples covering 8-normal, 4-Stage IA, 16-IB, 2-IIA, 12-IIB, 3-IIIA, 2-IIIB, 1-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
2 Weeks*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Lung Cancer cDNA Array I
Clinical Info
Diagnosis Category Lung Cancer
Tissue Lung
Shipping Ambient
Description 48 samples covering 8-normal, 4-Stage IA, 16-IB, 2-IIA, 12-IIB, 3-IIIA, 2-IIIB, 1-IV. Available in 2, 5, 10 identical plates.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9
Fu, Pajulas, Wang et al
Nat Commun (2022) 13 (1), 3811 DOI: 10.1038/s41467-022-31596-7
Cited by 35
AI Summary: OriGene contributed to this study by providing lung sections and RNA samples, which were used for analyzing gene expression and histological features relevant to the role of IL-9 signaling in lung cancer.
Snippet: nors for biobank submission provided written consent. Lung cancer serum was purchased from the Indiana Clinical and Translational Sciences Institute. Lung sections and RNA samples were purchased from OriGene. Detailed information is listed in Supplementary Tables 1–3. Cell lines B16-F10 melanoma cell line was a gift from Dr. Dario Vignali and Dr. Kai Yang. LLC (LL/2-Luc2) and H838 lung cancer
FigureFigureFigure
Calibration-free NGS quantitation of mutations below 0.01% VAF
Dai, Wu, Chen et al
Nat Commun (2021) 12 (1), 6123 DOI: 10.1038/s41467-021-26308-6
Cited by 37
AI Summary: In this study, OriGene’s AML-20 Reference Standard (HD829) and BRAF V600E Reference Standard (HD734) were used as control materials to validate the sensitivity and accuracy of the QBDA method for detecting low-frequency mutations.
FigureFigureFigure
TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target
Liu, Lv, Wei et al
Acta Pharm Sin B (2021) 11 (10), 3105-3119 DOI: 10.1016/j.apsb.2021.06.017
Cited by 36
AI Summary: In this study, OriGene products including TRIB3 shRNA (OriGene, #TL313678) and GSK-3β shRNA (OriGene, #TL313659) were used to specifically knock down TRIB3 and GSK-3β expression, enabling the authors to elucidate the functional roles of these proteins in promoting lung fibrosis.
FigureFigureFigure
TAF15 contributes to the radiation-inducible stress response in cancer
Singh, Kapoor, Thotala et al
Oncotarget (2020) 11 (27), 2647-2659 DOI: 10.18632/oncotarget.27663
Cited by 27
AI Summary: OriGene’s lung cancer tissue microarray was used for immunohistochemistry analyses to assess TAF15 expression in cancer tissues in this study.
Snippet: Immunohistochemistry. Immunohistochemistry for lung cancer (Origene) and healthy tissue microarray (Biochain) was performed as described earlier [41]. Briefly, TMA sections were de-waxed in xylene and then rehydrated in a graded alcohol series
FigureFigureFigure
Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions
Jin, Hong, Kim et al
Anticancer Res. (2019) 39 (12), 6723-6730 DOI: 10.21873/anticanres.13887
Cited by 38
AI Summary: OriGene contributed to this study by providing human lung cancer tissue samples (catalog numbers CP565586, CP565414, CP565564, and CP565534), which were used to analyze PSAT1 expression in various NSCLC subtypes.
Snippet: large cell carcinoma, #CP565586), lung cancer stage IIIA #6 (adenocarcinoma, #CP565414), lung cancer stage IIIA #7 (squamous carcinoma, #CP565564), and lung cancer stage IIIA #8 (large cell carcinoma, #CP565534) were purchased from OriGene Technologies
Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor
Wu, Huang, Hsieh et al
Mol. Cell (2019) 77 (2), 213-227.e5 DOI: 10.1016/j.molcel.2019.10.023
AI Summary: OriGene’s TissueScan Lung Cancer Tissue qPCR Panels I-IV (HLRT101, HLRT102, HLRT103, HLRT104) were used in this study to analyze SUCNR1 expression across lung cancer tissue samples, helping to demonstrate elevated SUCNR1 levels in lung cancer patients compared to controls.
Snippet: issueScan Lung Cancer Tissue qPCR Panels I OriGene Technologies HLRT101 TissueScan Lung Cancer Tissue qPCR Panels II OriGene Technologies HLRT102 TissueScan Lung Cancer Tissue qPCR Panels III OriGene Technologies HLRT103 TissueScan Lung Cancer Tissue qPCR Panels IV OriGene Technologies HLRT104
Showing 1-6 of 20 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products